← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 1999Last known activity
Oct 8, 2024
Timeline
1910s
- Jan 1, 1910
The Forsyth Institute— Founded
Drugs by trial phase (11 distinct, 8 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06464939CollaboratorPhase 2Oct 8, 2024
- NCT02342691Lead sponsorPhase 1/Phase 2Sep 1, 2016
- NCT03196648CollaboratorN/AMay 1, 2015
- NCT03196648Overall official - principal investigatorN/AMay 1, 2015
- NCT01577485CollaboratorPhase 1Aug 1, 2012
- NCT00309322Overall official - principal investigatorPhase 2Mar 1, 2006
- NCT00066066Lead sponsorPhase 2Jul 1, 2003
- NCT00066066Overall official - principal investigatorPhase 2Jul 1, 2003
- NCT00066001Lead sponsorPhase 2Dec 1, 2002
- NCT01098448Lead sponsorPhase 3Sep 1, 1999
- NCT01098448Overall official - principal investigatorPhase 3Sep 1, 1999
Details
- Founded
- Cambridge, MA, US Jan 1, 1910
- Last known activity
- Oct 8, 2024